Cart
sales@molnova.com
Kaempferol 3-O-(6-galloyl)-beta-D-glucopyranoside
CAS No. 56317-05-6
Kaempferol 3-O-(6-galloyl)-beta-D-glucopyranoside( —— )
Catalog No. M37787 CAS No. 56317-05-6
Kaempferol 3-O-(6''-galloyl)-beta-D-glucopyranoside is a glucopyranoside that inhibits HIV-2 RNase H with an IC50 of 5.19 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 170 | Get Quote |
|
| 5MG | 274 | Get Quote |
|
| 10MG | 499 | Get Quote |
|
| 25MG | 778 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKaempferol 3-O-(6-galloyl)-beta-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaempferol 3-O-(6''-galloyl)-beta-D-glucopyranoside is a glucopyranoside that inhibits HIV-2 RNase H with an IC50 of 5.19 μM.
-
DescriptionKaempferol-3-O-(6′′-galloyl)-β-glucopyranoside is a glucopyranoside. Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside inhibts HIV-2 RNase H with an IC50 value of 5.19 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56317-05-6
-
Formula Weight600.48
-
Molecular FormulaC28H24O15
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C1=C(OC=2C(C1=O)=C(O)C=C(O)C2)C3=CC=C(O)C=C3)[C@@H]4O[C@H](COC(=O)C5=CC(O)=C(O)C(O)=C5)[C@@H](O)[C@H](O)[C@H]4O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside. PubChem. 2022.12.21.
molnova catalog
related products
-
ABX464
ABX464 (ABX-464, ABX 464) is a novel class of anti-HIV small molecule targeting Rev-mediated viral RNA biogenesis.
-
HIV-1 integrase inhi...
HIV-1 integrase inhibitor 8 is an inhibitor of HIV-1 integrase, a critical enzyme necessary for the integration step in HIV replication .
-
Enfuvirtide
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.
